News | July 29, 2011

Varian to Showcase New, Updated Cancer Treatment Products at 2011 AAPM/COMP

July 29, 2011 – Varian Medical Systems' next release of the Aria oncology information system, newly designed for greater ease of use, will be among the highlights of the company’s exhibit at the 2011 joint meeting of the American Association of Physicists in Medicine (AAPM) and the Canadian Organization of Medical Physicists (COMP) here later this week. Varian will also demonstrate SmartConnect for TrueBeam, a utility that enables secure remote servicing of a TrueBeam cancer treatment machine. Varian personnel in the exhibit hall will use SmartConnect to monitor and evaluate a TrueBeam cancer treatment system 1300 miles away in Las Vegas, N.V.

ARIA Oncology Information System – Version 11

The next release of Varian's Aria oncology information system, a software program for managing advanced cancer treatment protocols, has been redesigned for greater ease of use and will also be on display. Aria Version 11 was recently certified as meeting the requirements for use as an electronic medical record (EMR) under the HITECH Act, which means it can be used to qualify for incentive payments under Medicare.  

Aria Version 11 incorporates a new icon-oriented interface using easily recognized pictures and symbols rather than words to guide navigation. Users can configure a personalized home screen to serve as a dashboard that aggregates frequently used information and utilities in one place.  

Aria Version 11 is also more tightly integrated with Eclipse treatment planning so that users can access tasks in either system from Aria screens without launching different programs. Pre-programmed task sequences offer greater automation and standardization. The system can be configured to present users with tasks in the proper sequence based on a treatment center's approved workflow protocols. Rules and checklists can be attached to tasks and required by the system before a treatment can progress.

The TrueBeam System and SmartConnect

Varian will also showcase the TrueBeam system for image-guided radiotherapy and stereotactic body radiotherapy (SBRT), which was designed to treat tumors with unprecedented speed and accuracy — including tumors that move during treatment as the patient breathes. SmartConnect enables remote servicing of TrueBeam, reducing the frequency and duration of onsite service calls and sometimes eliminating them altogether.

"With SmartConnect, Varian's clinical experts can remotely see exactly what our customers see in real time, and deal with any problems faster than would be possible if we were dispatching a service engineer to the site," said Kevin O'Reilly, senior director of customer support services marketing. "We can work with customers as if we were right beside them, identify problems and implement solutions quickly."

Smart Segmentation Knowledge-Based Contouring

Varian's Smart Segmentation knowledge-based contouring tool, which has been fully integrated with Eclipse treatment planning, will also be exhibited. This tool automates and accelerates the most time-consuming portion of the treatment planning process, using "smart" software to automatically identify and outline organs and other structures within diagnostic images so that doctors can specify structures to be irradiated or protected during radiotherapy treatments.  

The tool can also perform automatic contouring based on pre-contoured images from a database created by renowned radiation oncologists. This significantly reduces the need for clinicians to manually outline between 10 and 20 organs in each of anywhere from 100 to 200 images of a patient's disease site. Clinicians can start the planning process with images that have important anatomical structures already outlined, and adjust them according to their clinical judgment. "It's similar to building a house from scratch or remodeling," said Jeff Amacker, business manager for treatment planning systems. "Remodeling is generally much faster because you have something to work from."

Varian Users Meeting at AAPM

Varian will conduct a Users Meeting on Saturday, July 30, from 11 a.m. to 6 p.m., when experts from across North America will cover topics including: user-centric software solutions for patient-centric care; the treatment of lung cancer using RapidArc technology to deliver stereotactic body radiotherapy (SBRT); enhancing safety through quality assurance techniques; and high-dose-rate brachytherapy for gynecological cancer treatment.

For more information: www.varian.com

 

Related Content

Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...